McKesson | MCK - Selling And Administration Expenses

Stock Price
947.48
Daily Change
10.34 1.10%
Monthly
15.09%
Yearly
58.52%
Q1 Forecast
918.11

McKesson reported $2.03B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Acadia Healthcare USD 2.28B 1.77B Sep/2025
Align Technology USD 441.68M 23.88M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Centene USD 3.37B 236M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cigna USD 3.19B 242M Sep/2025
Community Health Systems USD 10.59B 251M Sep/2025
Computer Programs Systems USD 161.36M 1.74M Sep/2025
DaVita Healthcare Partners USD 472.36M 57.99M Dec/2025
Dentsply International USD 355M 21M Sep/2025
eHealth USD 69.42M 70.12M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Encompass Health USD 68.4M 12.3M Dec/2025
HCA USD 38.4B 978M Sep/2025
Henry Schein USD 760M 17M Sep/2025
Humana USD 3.36B 614M Mar/2025
IQVIA Holdings USD 468M 46M Dec/2025
J&J USD 6.75B 831M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
McKesson USD 2.03B 44M Dec/2025
Molina Healthcare USD 1.33B 98M Dec/2025
Owens Minor USD 462.35M 30.72M Mar/2025
Quest Diagnostics USD 504M 3M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tenet Healthcare USD 102M 2.06B Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Universal Health Services USD 414.58M 4.2M Sep/2025
Veradigm USD 32.52M 27.13M Sep/2022